Earnings Call · Q2 FY2021·2021-08-12

Q2 21EPS -6.52%·Rev n/aQ1 21EPS +17.31%·Rev n/aQ4 20EPS -15.91%·Rev n/aQ3 20EPS +19.61%·Rev n/a⚠ consensus missing

Trevi Therapeutics, Inc. TRVI

Jennifer Good — Chief Financial Officer

−4.0%1d on move date−4.2% vs SPY3d−8.6%5d−22.4%

Research tier

Behavioral profile computed for this call's speaker on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRVI calls or request research access.

More TRVI calls Browse calls Request research access